Amedeo Smart

Free Medical Literature Service

 

Amedeo

Autoimmune Disorders
  Free Subscription

Articles published in
Am J Kidney Dis
    September 2025
  1. BU L, Lee JH, Quigley MM, Elahimehr R, et al
    IgG3kappa Monoclonal Membranous Nephropathy Associated With Acquired Lecithin Cholesterol Acyltransferase Deficiency.
    Am J Kidney Dis. 2025 Sep 18:S0272-6386(25)01024.
    >> Share

    June 2025
  2. CHUNG EY, Carter SA, Jaure A, Howell M, et al
    Patients' Perspectives on Living With Primary Membranous Nephropathy: A Semi-Structured Interview Study.
    Am J Kidney Dis. 2025 Jun 17:S0272-6386(25)00908.
    >> Share

    May 2025

  3. Erratum regarding "Lupus Nephritis Patterns and Response to Type I Interferon in Patients With DNASE1L3 Variants: Report of Three Cases" (Am J Kidney Dis. 2024;84(6):791-797).
    Am J Kidney Dis. 2025;85:666.
    >> Share

    March 2025
  4. MORELLE J, Aydin S, Debiec H, Demoulin N, et al
    Mass Spectrometry With Data-Independent Acquisition for the Identification of Target Antigens in Membranous Nephropathy.
    Am J Kidney Dis. 2025 Mar 7:S0272-6386(25)00717.
    >> Share

  5. BU L, Valeri AM, Said SM, Zhu Y, et al
    IgM Variant of Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits: A Case Series.
    Am J Kidney Dis. 2025 Mar 6:S0272-6386(25)00712.
    >> Share

    September 2024
  6. FRIMAT M, Maanaoui M, Schwotzer N, Lebas C, et al
    Non-Plasmapheresis Approaches for Managing Severe Renal Thrombotic Microangiopathy: A Report of 7 Cases.
    Am J Kidney Dis. 2024 Sep 27:S0272-6386(24)00978.
    >> Share

  7. FISCHMAN CJ, Holzman LB
    Identification of Nephrin Autoantibodies Signals New Chapter for Glomerular Disease.
    Am J Kidney Dis. 2024 Sep 18:S0272-6386(24)00972.
    >> Share

  8. ZENI L, Mescia F, Toso D, Dordoni C, et al
    Clinical Significance of the Cystic Phenotype in Alport Syndrome.
    Am J Kidney Dis. 2024;84:320-328.
    >> Share

    August 2024
  9. DE COS M, Mosoyan G, Chauhan K, Troost JP, et al
    Urinary Plasminogen as a Marker of Disease Progression in Human Glomerular Disease.
    Am J Kidney Dis. 2024;84:205-214.
    >> Share

  10. VON SAMSON-HIMMELSTJERNA FA, Kakavand N, Voran JC, Kolbrink B, et al
    Use of Immunoadsorption and Plasma Exchange for Treating Anti-Glomerular Basement Membrane Disease: Clinical Experience in Germany.
    Am J Kidney Dis. 2024;84:255-258.
    >> Share

    July 2024
  11. VOLPI S, Angelotti ML, Palazzini G, Antonelli G, et al
    Lupus Nephritis Patterns and Response to Type I Interferon in Patients With DNASE1L3 Mutations: Report of Three Cases.
    Am J Kidney Dis. 2024 Jul 24:S0272-6386(24)00892.
    >> Share

  12. IVKOVIC V, Kronbichler A, Caza TN
    "Atypical" Anti-GBM Disease: Just Atypical, or Not Anti-GBM Disease at All?
    Am J Kidney Dis. 2024;84:127-129.
    >> Share

  13. CHAUVEAU B, Gibier JB, Rabant M
    In Reply to "'Atypical' Anti-GBM Disease: Just Atypical, or Not Anti-GBM Disease at All?".
    Am J Kidney Dis. 2024;84:129.
    >> Share

    June 2024
  14. NAKAYAMA T, Kaneko H, Suzuki Y, Okada A, et al
    Chronic Tonsillitis and IgA Nephropathy: Findings From a Nationwide Japanese Cohort Study.
    Am J Kidney Dis. 2024 Jun 19:S0272-6386(24)00832.
    >> Share

  15. CORNELL LD
    Anti-Glomerular Basement Membrane Disease: Broadening the Spectrum.
    Am J Kidney Dis. 2024;83:701-703.
    >> Share

  16. CHAUVEAU B, Gibier JB, Olagne J, Morel A, et al
    Atypical Anti-Glomerular Basement Membrane Nephritis: A Case Series From the French Nephropathology Group.
    Am J Kidney Dis. 2024;83:713-728.
    >> Share

    May 2024
  17. SASAKI T, Tsuboi N
    Time-Varying Proteinuria in Predicting Outcome of IgA Nephropathy.
    Am J Kidney Dis. 2024 May 11:S0272-6386(24)00755.
    >> Share

    March 2024
  18. HONDA D, Okunaga I, Omote D, Inoue H, et al
    Anti-Neuron-Derived Neurotrophic Factor Antibodies in Secondary Membranous Nephropathy Caused by Syphilis: A Case Report.
    Am J Kidney Dis. 2024 Mar 22:S0272-6386(24)00685.
    >> Share

    February 2024
  19. TANG C, Chen P, Si FL, Lv JC, et al
    Time-Varying Proteinuria and Progression of IgA Nephropathy: A Cohort Study.
    Am J Kidney Dis. 2024 Feb 14:S0272-6386(24)00609.
    >> Share

    January 2024
  20. MIGNANO SE, Pascal V, Odioemene NE, Forehand W, et al
    Monoclonal Immunoglobulin Crystalline Membranous Nephropathy.
    Am J Kidney Dis. 2024 Jan 22:S0272-6386(24)00041.
    >> Share

  21. BECK LH JR
    Quantity Versus Quality of Anti-Phospholipase A2 Receptor 1 Autoantibodies in the Assessment of Clinical Outcome in Membranous Nephropathy: The Debate Continues.
    Am J Kidney Dis. 2024 Jan 22:S0272-6386(23)00995.
    >> Share

  22. PAUEKSAKON P, Najafian B, Alpers CE, Fogo AB, et al
    AJKD Atlas of Renal Pathology: IgA-Dominant Infection-Related Glomerulonephritis.
    Am J Kidney Dis. 2024;83:e1-e2.
    >> Share

  23. WANG CS, Glenn DA, Helmuth M, Smith AR, et al
    Association of COVID-19 Versus COVID-19 Vaccination With Kidney Function and Disease Activity in Primary Glomerular Disease: A Report of the Cure Glomerulonephropathy Study.
    Am J Kidney Dis. 2024;83:37-46.
    >> Share

    December 2023
  24. MASSICOTTE-AZARNIOUCH D, Detwiler RK, Hu Y, Falk RJ, et al
    Infections Following Kidney Transplantation After Exposure to Immunosuppression for Treatment of Glomerulonephritis.
    Am J Kidney Dis. 2023 Dec 29:S0272-6386(23)01000.
    >> Share

  25. RUGGENENTI P, Reinhard L, Ruggiero B, Perna A, et al
    Anti-Phospholipase A2 Receptor 1 and Anti-Cysteine Rich Antibodies, Domain Recognition and Rituximab Efficacy in Membranous Nephropathy: A Prospective Cohort Study.
    Am J Kidney Dis. 2023 Dec 25:S0272-6386(23)00993.
    >> Share

  26. CANNEY M, Gunning HM, Johnston JC, Induruwage D, et al
    Incidence of and Risk Factors for Active Tuberculosis Disease in Individuals With Glomerular Disease: A Canadian Cohort Study.
    Am J Kidney Dis. 2023;82:725-736.
    >> Share

    September 2023
  27. PODESTA MA, Trillini M, Portalupi V, Gennarini A, et al
    Ofatumumab in Rituximab-Resistant and Rituximab-Intolerant Patients With Primary Membranous Nephropathy.
    Am J Kidney Dis. 2023 Sep 28:S0272-6386(23)00838.
    >> Share

  28. CASTER DJ, Lafayette RA
    The Treatment of Primary IgA Nephropathy: Change, Change, Change.
    Am J Kidney Dis. 2023 Sep 22:S0272-6386(23)00831.
    >> Share

  29. AFOLABI H, Zhang BM, O'Shaughnessy M, Chertow GM, et al
    The Association of Class I and II Human Leukocyte Antigen Serotypes With End-Stage Kidney Disease Due to Membranoproliferative Glomerulonephritis and Dense Deposit Disease.
    Am J Kidney Dis. 2023 Sep 18:S0272-6386(23)00797.
    >> Share

  30. KEARNEY AO, Lerma E, Lin J
    Building Towards Clinical Translation: New Study Refines Genetic Architecture of IgA Nephropathy.
    Am J Kidney Dis. 2023 Sep 14:S0272-6386(23)00794.
    >> Share

  31. ELEY S, Morales-Alvarez MC, Vanguri VK, Chopra B, et al
    An Unusual Case of Anti-Glomerular Basement Membrane Disease and PLA2R-Associated Membranous Nephropathy After Exposure to Hydrocarbons.
    Am J Kidney Dis. 2023 Sep 13:S0272-6386(23)00793.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016